UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934

Date of Report (Date of earliest event reported):  May 29, 2019
BRISTOL-MYERS SQUIBB COMPANY
(Exact Name of Registrant as Specified in its Charter)
Delaware
1-1136
22-0790350
(State or Other
Jurisdiction of
Incorporation)
(Commission File
Number)
(IRS Employer
Identification
Number)

430 East 29th Street, 14th Floor
New York, NY 10016
(Address of Principal Executive Office)

Registrant’s telephone number, including area code: (212) 546-4000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  Securities registered pursuant to Section 12(b) of the Act:


Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.10 Par Value
BMY
New York Stock Exchange
1.000% Notes due 2025
 
New York Stock Exchange
1.750% Notes due 2035
 
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company          ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.          ☐
I tem 5.07. Submission of Matters to a Vote of Security Holders.

(a) The Annual Meeting of the Company was held on May 29, 2019.

(b) Shareholders voted on the matters set forth below.

Item 1. The shareholders elected each of the Company’s 11 nominees to serve as directors of the Company until the 2020 Annual Meeting based upon the following votes:

   
For
   
Against
   
Abstain
   
Broker
Non-Vote
 
Peter J. Arduini
   
1,155,365,328
     
36,200,206
     
3,857,834
       
257,978,362
 
Robert J. Bertolini
   
1,150,832,715
     
40,783,094
     
3,807,559
       
257,978,362
 
Giovanni Caforio, M.D.
   
1,120,087,179
     
63,748,810
     
11,587,379
       
257,978,362
 
Matthew W. Emmens
   
1,175,827,887
     
15,719,788
     
3,875,693
       
257,978,362
 
Michael Grobstein
   
1,136,740,879
     
54,812,057
     
3,870,432
       
257,978,362
 
Alan J. Lacy
   
1,141,436,693
     
49,932,224
     
4,054,451
       
257,978,362
 
Dinesh C. Paliwal
   
1,142,575,999
     
48,744,977
     
4,102,392
       
257,978,362
 
Theodore R. Samuels
   
1,152,218,669
     
39,148,455
     
4,056,244
       
257,978,362
 
Vicki L. Sato, Ph.D.
   
1,093,762,348
     
73,584,882
     
28,076,138
       
257,978,362
 
Gerald L. Storch
   
1,151,710,225
     
39,667,853
     
4,045,290
       
257,978,362
 
Karen H. Vousden, Ph.D.
   
1,177,834,006
     
13,842,259
     
3,747,103
       
257,978,362
 

Item 2. The management proposal on the advisory vote to approve the compensation of our named executive officers was approved based upon the following votes:

For
   
Against
   
Abstain
   
Broker
Non-Vote
 
1,104,120,140
   
83,372,093
   
7,931,135
   
257,978,362
 

Item 3.   The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2019 was ratified based upon the following votes:

For
   
Against
   
Abstain
 
1,399,501,334
   
48,237,267
   
5,663,129
 

Item 4.   The shareholder proposal on shareholder right to act by written consent was not approved based upon the following votes:

For
   
Against
   
Abstain
   
Broker
Non-Vote
 
521,251,648
   
662,700,015
   
11,471,705
   
257,978,362
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
BRISTOL-MYERS SQUIBB COMPANY
       
Dated: May 30, 2018
By:
/s/ Katherine R. Kelly
   
Name:
Katherine R. Kelly
   
Title:
Corporate Secretary